| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c79f1eeee09195bc97b775583349eacd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-08 |
| filingDate |
2002-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c86e76cf7620595d94b1da41b828801a |
| publicationDate |
2004-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1448219-A1 |
| titleOfInvention |
Antiglaucomatous agent and use thereof |
| abstract |
The present invention relates to pharmaceutical compositions based on antiglaucomatous active ingredients and to the use thereof for the treatment of glaucomas. The compositions comprise lactalbumin hydrolysate or a fraction thereof. Substantially lower doses of the antiglaucomatous agents are thus possible than is conventionally necessary to achieve a particular antiglaucomatous effect. |
| priorityDate |
2001-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |